These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 12519356)

  • 1. In vitro effects of cefotaxime and ceftriaxone on Salmonella typhi within human monocyte-derived macrophages.
    Ekinci B; Coban AY; Birinci A; Durupinar B; Erturk M
    Clin Microbiol Infect; 2002 Dec; 8(12):810-3. PubMed ID: 12519356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of ampicillin, ceftriaxone, chloramphenicol, pefloxacin and trimethoprim-sulphamethoxazole on Salmonella typhi within human monocyte-derived macrophages.
    Chang HR; Vladoianu IR; Pechère JC
    J Antimicrob Chemother; 1990 Nov; 26(5):689-94. PubMed ID: 2079450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A simple broth-disk method to determine the minimum inhibitory concentration of ceftriaxone on Salmonella enterica serovar typhi and paratyphi.
    Bhat KG; Tripathy A; Rajagopal R; Ramachandran S
    Indian J Pathol Microbiol; 2009; 52(2):189-90. PubMed ID: 19332908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Bactericidal activity of 6 antibiotics and 3 combinations against 6 strains of Salmonella isolated from blood].
    Chevalier B; Cavallo JD; Meyran M
    Pathol Biol (Paris); 1995 Apr; 43(4):264-9. PubMed ID: 7567112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increase in minimum inhibitory concentration to quinolones and ceftriaxone in salmonellae causing enteric fever.
    Sekar U; Srikanth P; Kindo AJ; Babu VP; Ramasubramanian V
    J Commun Dis; 2003 Sep; 35(3):162-9. PubMed ID: 15796408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multi-drug-resistant Salmonella typhi--a need for therapeutic reappraisal.
    Gulati S; Marwaha RK; Prakash D; Ayyagari A; Singhi S; Kumar L; Singhi P; Walia BN
    Ann Trop Paediatr; 1992; 12(2):137-41. PubMed ID: 1381886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapy of multidrug resistant typhoid in 58 children.
    Naqvi SH; Bhutta ZA; Farooqui BJ
    Scand J Infect Dis; 1992; 24(2):175-9. PubMed ID: 1641594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activity of cefixime versus ceftizoxime against Salmonella typhi.
    Rastegar Lari A; Validi N; Ghaffarzadeh K; Shamshiri AR
    Pathol Biol (Paris); 1997 May; 45(5):415-9. PubMed ID: 9296095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Occurrence and antibacterial susceptibility pattern of bacterial pathogens isolated from diarrheal patients in Pakistan.
    Rasool MH; Siddique AB; Saqalein M; Asghar MJ; Zahoor MA; Aslam B; Shafiq HB; Nisar MA
    Saudi Med J; 2016 Mar; 37(3):274-9. PubMed ID: 26905349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro killing of penicillin-susceptible, -intermediate, and -resistant strains of Streptococcus pneumoniae by cefotaxime, ceftriaxone, and ceftizoxime: a comparison of bactericidal and inhibitory activity with achievable CSF levels.
    Stratton CW; Aldridge KE; Gelfand MS
    Diagn Microbiol Infect Dis; 1995; 22(1-2):35-42. PubMed ID: 7587048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro efficacy of the combination of ciprofloxacin and cefotaxime against nalidixic acid-resistant Salmonella enterica serotype Typhi.
    Kim DM; Neupane GP; Jang SJ; Kim SH; Lee BK
    Int J Antimicrob Agents; 2010 Aug; 36(2):155-8. PubMed ID: 20478696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Susceptibilities of ampicillin-resistant strains of Salmonella other than S. typhi to 10 antimicrobial agents.
    Alós JI; Gómez-Garcés JL; Cogollos R; Amor E; Pérez-Rivilla A
    Antimicrob Agents Chemother; 1992 Aug; 36(8):1794-6. PubMed ID: 1416869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences between ceftriaxone and cefotaxime: microbiological inconsistencies.
    Gums JG; Boatwright DW; Camblin M; Halstead DC; Jones ME; Sanderson R
    Ann Pharmacother; 2008 Jan; 42(1):71-9. PubMed ID: 18094350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multi-drug resistant Salmonella enterica serovar Typhi isolates with reduced susceptibility to ciprofloxacin in Kenya.
    Mutai WC; Muigai AWT; Waiyaki P; Kariuki S
    BMC Microbiol; 2018 Nov; 18(1):187. PubMed ID: 30428828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current pattern in antimicrobial susceptibility of Salmonella Typhi isolates in Pondicherry.
    Madhulika U; Harish BN; Parija SC
    Indian J Med Res; 2004 Aug; 120(2):111-4. PubMed ID: 15347861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [In vitro antibacterial activity of a new cephalosporin: cefpirome (HR 810). Comparison with ceftriaxone, cefotaxime, latamoxef and ceftazidime].
    Le Noc P; Bryskier A; Le Noc D
    Pathol Biol (Paris); 1986 Jun; 34(5 Pt 2):567-71. PubMed ID: 3534744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multidrug-resistant Salmonella typhi in Pakistani children: clinical features and treatment.
    Rathore MH; Bux D; Hasan M
    South Med J; 1996 Feb; 89(2):235-7. PubMed ID: 8578359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The susceptibility of Salmonella sp. to various antibiotics].
    Willke A; Altay G; Erdem B
    Mikrobiyol Bul; 1988 Jan; 22(1):17-24. PubMed ID: 3273593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug resistance patterns in Salmonella enterica subspecies enterica serotype Typhi strains isolated over a period of two decades, with special reference to ciprofloxacin and ceftriaxone.
    Nath G; Maurya P
    Int J Antimicrob Agents; 2010 May; 35(5):482-5. PubMed ID: 20188522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bactericidal activities of chloramphenicol and eleven other antibiotics against Salmonella spp.
    Preblud SR; Gill CJ; Campos JM
    Antimicrob Agents Chemother; 1984 Mar; 25(3):327-30. PubMed ID: 6372681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.